This is a dynamic purchasing system or similar standing arrangement, not a one-off tender.
Suppliers can apply to join at any time until 31 December 2026. The buyer then invites admitted suppliers to compete for individual contracts, each with its own short deadline.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)
Germany – Pharmaceutical products – Open House Biologika discount contracts 2026-24 - Aflibercept (ATC: S01LA05); Efficacy: 40 mg/mlEnglish, machine translated
Issued by Techniker Krankenkasse · via TED — Tenders Electronic Daily (EU)
- Published
- 18 Nov 2026
- Open to join until
- 31 Dec 2026, 23:59 UTC
- Reference
- 802789-2026
- Location
- Germany
- Sector
- Healthcare & Pharma
- Type
- goods
At a glance
Techniker Krankenkasse in Germany has published an open-admission purchasing arrangement in healthcare & pharma: “Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)”. Suppliers can apply to join until 31 December 2026. Quote reference 802789-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 109 notices from this buyer since 2026, 80 of them currently open. There are 880 open healthcare & pharma notices in Germany on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on EU public procurement
Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.
English summary
Machine translated from German by FreeTender. The original notice below is the binding text.
TK pursues the goal of rebate agreements with all suitable pharmaceutical companies in accordance with § 130a para 8 SGB V on the active substance Aflibercept (ATC: S01LA05); Effectiveness: 40 mg/ml. The contract is concluded within the framework of the Open House procedure of the TK: Individual negotiations on contract contents are not conducted, uniform conditions apply. TK does not guarantee any exclusivity to individual contractual partners. The term of the contract is a maximum of 12 months starting on 01.08.2026.
Details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml) zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 12 Monate beginnend mit dem 01.08.2026. Der Vertrag endet spätestens am 31.07.2027, unabhängig vom Datum des Vertragsschlusses. Der Vertrag kann um 12 Monate verlängert werden. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen.
Lots Lot 1 — Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml): Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml) zu schließen.
Buyer: Techniker Krankenkasse
Buyer country: DEU
Procedure: open
CPV code: 33600000
Full notice, tender documents and how to bid are on the official TED page (link above).
Context for bidders
We hold 109 notices from Techniker Krankenkasse, going back to August 2026 — 80 of them still open. They buy mostly in Healthcare & Pharma, IT & Telecom and Construction & Infrastructure. There are 880 open Healthcare & Pharma tenders in Germany. This one closes in 44 days.
More from this buyer
- Open-House-Biologika-Rabattverträge 2026-09 - Etanercept· closes 31 Dec
- Open House Biologika Rabattverträge 2026 - 15 Ranibizumab· closes 30 Jun
- Open House Biologika Rabattverträge 2026-36 Anakinra· closes 31 Dec
- Open House Biologika Rabattverträge 2026 - 12 Epoetin alfa und Epoetin zeta· closes 31 Dec
- Open-House-Biologika-Rabattverträge 2026-08 - Filgrastim· closes 30 Apr
Similar Healthcare & Pharma tenders
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 12 Epoetin alfa und Epoetin zeta· closes 31 Dec
- Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)· closes 31 Dec
- Open-House-Biologika-Rabattverträge 2026-05 - Pegfilgrastim· closes 30 Apr
- Germany – Health services – Betriebsführung zur Abwicklung der Beschaffungsprozesse im Zusammenhang mkit der COVID-19-Pandemie· closes 19 Nov
- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-05 - Pegfilgrastim· closes 30 Apr
Explore Germany
Documents
- TED-official-notice-802789-2026.pdfDownload (pdf)
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Who won similar contracts
Recent contract awards in Germany, from published award notices.
- Suivi et Contrôle des travaux d'alimentation en eau potable d'Issia et localités environnantesWon by GOPA - International Energy Consultants GmbH (Allemagne) · XOF 151,478,080.00 · 30 Sept 2026
- Supervision of works for Viroi bridgeWon by Schneider & Partner Ingenieur-consult GMBH (Germany) · EUR 140,000.00 · 18 Aug 2026
More Healthcare & Pharma tenders
- Поставка лекарственного препарата КАЛИЯ ХЛОРИДТАМБОВСКОЕ ОБЛАСТНОЕ ГОСУДАРСТВЕННОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ "РЕГИОНАЛЬНЫЙ ЦЕНТР ПО ОРГАНИЗАЦИИ ЗАКУПОК" · Russia
- Поставка парентерального питания для больницы «ГБУЗ ГБК им.А.К.Ерамишанцева ДЗМ» (Повторно)ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ ГОРОДА МОСКВЫ "ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА ИМЕНИ А.К. ЕРАМИШАНЦЕВА ДЕПАРТАМЕНТА ЗДРАВООХРАНЕНИЯ ГОРОДА МОСКВЫ" · Russia
- Поставка лекарственных препаратов для медицинского применения - 13 МНН: УстекинумабФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ НАУЧНО-КЛИНИЧЕСКИЙ ЦЕНТР ДЕТЕЙ И ПОДРОСТКОВ ФЕДЕРАЛЬНОГО МЕДИКО-БИОЛОГИЧЕСКОГО АГЕНТСТВА" · Russia
- Поставка расходных материалов для эндоскопического отделения ГБУЗ РА Адыгейская республиканская клиническая больницаКОМИТЕТ РЕСПУБЛИКИ АДЫГЕЯ ПО РЕГУЛИРОВАНИЮ КОНТРАКТНОЙ СИСТЕМЫ В СФЕРЕ ЗАКУПОК · Russia
- Лекарственные препараты (2-ЖВ) для ГБУ РО ЦРБ в Зерноградском районе в 2027 г.ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ РОСТОВСКОЙ ОБЛАСТИ "ЦЕНТРАЛЬНАЯ РАЙОННАЯ БОЛЬНИЦА" В ЗЕРНОГРАДСКОМ РАЙОНЕ · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →